Norvir (Ritonavir)
HIV Protease Inhibitor – Pharmacokinetic Booster
Norvir (ritonavir) is an antiretroviral medicine used as a pharmacokinetic booster in combination with other HIV protease inhibitors. By inhibiting the CYP3A4 liver enzyme, ritonavir increases the blood levels of co-administered protease inhibitors, making them more effective at controlling HIV infection. It is approved for use in adults and children aged 2 years and older.
Quick Facts
Key Takeaways
- Norvir (ritonavir) is primarily used as a pharmacokinetic booster, not as a standalone HIV treatment at typical doses.
- It works by inhibiting CYP3A4, a liver enzyme responsible for metabolizing many medications, thereby raising blood levels of co-administered protease inhibitors.
- Norvir has extensive drug interactions — many medications are absolutely contraindicated, including certain statins, sedatives, and ergot derivatives.
- Common side effects include gastrointestinal symptoms (nausea, diarrhea, vomiting), headache, dizziness, and tingling in extremities.
- Tablets must be swallowed whole with food — do not chew, crush, or break them.
What Is Norvir and What Is It Used For?
Quick Answer: Norvir (ritonavir) is an HIV protease inhibitor used primarily as a pharmacokinetic booster alongside other antiretroviral drugs. At low doses, it enhances the effectiveness of co-administered protease inhibitors by slowing their metabolism in the liver.
Norvir contains the active substance ritonavir, which belongs to a class of drugs known as HIV protease inhibitors. HIV protease is an enzyme that the human immunodeficiency virus (HIV) needs to produce new copies of itself. By inhibiting this enzyme, protease inhibitors can prevent the virus from replicating and spreading within the body.
However, in modern HIV treatment, ritonavir is rarely used at full therapeutic doses as a direct antiviral agent. Instead, it is used at low doses (typically 100–200 mg daily) as a pharmacokinetic enhancer, also known as a “booster.” In this role, ritonavir acts as a potent inhibitor of the liver enzyme cytochrome P450 3A4 (CYP3A4). This enzyme is responsible for breaking down many protease inhibitors in the body. When ritonavir inhibits CYP3A4, the co-administered protease inhibitor is metabolized more slowly, resulting in higher and more sustained blood levels. This boosting effect allows physicians to prescribe lower and less frequent doses of the primary protease inhibitor while still maintaining effective drug concentrations.
Your doctor will determine the best combination of antiretroviral medications for your individual situation. It is important to understand that Norvir as a booster does not directly treat HIV on its own — it works by enhancing the effectiveness of the partner protease inhibitor in your regimen. Common protease inhibitors that are boosted with ritonavir include atazanavir, darunavir, and lopinavir.
Norvir is approved for use in adults, adolescents, and children aged 2 years and older who are infected with HIV-1. The decision to use ritonavir-boosted protease inhibitor therapy is typically based on viral load testing, CD4 cell count, treatment history, and potential drug resistance patterns. International guidelines from organizations such as the WHO, DHHS, and BHIVA provide recommendations for when protease inhibitor-based regimens are most appropriate.
What Should You Know Before Taking Norvir?
Quick Answer: Norvir has numerous contraindications, significant drug interactions, and important precautions. Always provide your doctor with a complete list of all medications you are taking, including over-the-counter drugs and herbal supplements, before starting treatment.
Contraindications
Do not take Norvir if any of the following apply to you:
- You are allergic to ritonavir or any of the other ingredients in the tablet.
- You have severe liver disease.
- You are currently taking any of the following medications, as dangerous or life-threatening interactions may occur:
- Astemizole or terfenadine — antihistamines (risk of cardiac arrhythmia)
- Amiodarone, dronedarone, flecainide, propafenone, quinidine — antiarrhythmics (risk of serious cardiac events)
- Dihydroergotamine, ergotamine, ergonovine, methylergonovine — ergot derivatives (risk of ergotism with vasospasm and ischemia)
- Oral midazolam, triazolam, clorazepate, diazepam, estazolam, flurazepam — sedatives (risk of extreme sedation and respiratory depression)
- Clozapine, pimozide — antipsychotics (risk of cardiac arrhythmia)
- Quetiapine — antipsychotic (risk of severe sedation)
- Lurasidone — antidepressant/antipsychotic
- Ranolazine — anti-anginal (risk of serious cardiac events)
- Pethidine (meperidine), propoxyphene — opioid analgesics
- Cisapride — prokinetic agent (risk of cardiac arrhythmia)
- Simvastatin, lovastatin — statins (risk of rhabdomyolysis)
- Neratinib — breast cancer treatment
- Lomitapide — cholesterol-lowering agent
- Alfuzosin — alpha-blocker for prostate enlargement (risk of hypotension)
- Fusidic acid — antibiotic
- Sildenafil for pulmonary arterial hypertension (but may be used for erectile dysfunction at reduced doses under medical supervision)
- Avanafil, vardenafil — PDE5 inhibitors for erectile dysfunction
- Colchicine (for gout) — if you have kidney and/or liver problems
- St. John’s Wort (Hypericum perforatum) — may reduce ritonavir levels and cause treatment failure
If you are currently taking any of these medications, ask your doctor whether it is possible to switch to an alternative medicine while you are taking Norvir. The risk of using these drugs together with ritonavir can be fatal in some cases due to the dramatic increase in blood concentrations of the co-administered drug.
Warnings and Precautions
Talk to your doctor before taking Norvir, especially if you have any of the following conditions or concerns:
Norvir does not cure HIV infection or AIDS. People taking Norvir can still develop opportunistic infections and other conditions associated with HIV disease. It is important that you remain under the care of your doctor while taking this medicine.
- Liver disease — Inform your doctor of any history of liver disease, particularly hepatitis B or C. Patients with pre-existing liver conditions who are treated with combination antiretroviral therapy have an increased risk of severe and potentially life-threatening hepatic reactions. Regular blood tests to monitor liver function may be required.
- Hemophilia — Increased bleeding has been reported in patients with hemophilia type A and B who take protease inhibitors. You may need additional clotting factor (factor VIII) to control bleeding episodes.
- Erectile dysfunction medications — If you are taking drugs for erectile dysfunction (such as sildenafil or tadalafil), ritonavir can significantly increase their blood levels, potentially causing dangerously low blood pressure and prolonged erection (priapism).
- Diabetes — New-onset or worsening diabetes mellitus has been reported in some patients taking protease inhibitors. Blood glucose monitoring may be necessary.
- Kidney disease — Your doctor may need to adjust the doses of other medications in your regimen.
Tell your doctor immediately if you experience any of the following while taking Norvir:
- Persistent diarrhea or vomiting that does not improve, as this may reduce the effectiveness of your antiretroviral regimen.
- Nausea, vomiting, or abdominal pain — these may be signs of pancreatitis (inflammation of the pancreas), a serious condition that has been reported in some patients taking Norvir.
- Symptoms of new infection — When starting antiretroviral therapy, patients with advanced HIV infection may develop immune reconstitution inflammatory syndrome (IRIS). As the immune system recovers, it may begin to fight previously unrecognized infections, causing symptoms such as fever, swollen lymph nodes, or worsening of existing conditions. Autoimmune disorders (such as Graves’ disease or Guillain-Barré syndrome) may also occur months after starting treatment.
- Joint stiffness, pain, or difficulty moving (especially in hips, knees, and shoulders) — these may be signs of osteonecrosis (bone death), which has been reported in patients receiving combination antiretroviral therapy.
- Muscle pain, tenderness, or weakness — particularly when combined with protease inhibitors and nucleoside analogues. In rare cases, this can be severe (rhabdomyolysis).
- Dizziness, fainting, or abnormal heartbeat — ritonavir may cause changes in the electrocardiogram (ECG). Inform your doctor if you have any pre-existing heart problems or cardiac conduction disorders.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, or are planning to have a baby, it is very important to consult your doctor before taking Norvir. There is extensive data available on the use of ritonavir during pregnancy. In most cases, pregnant women received ritonavir as a booster with other protease inhibitors after the first trimester. Available evidence suggests that ritonavir does not appear to increase the risk of birth defects compared to the general population.
Breastfeeding is not recommended for women living with HIV, as the virus can be transmitted to the infant through breast milk. If you are breastfeeding or planning to breastfeed, discuss this with your doctor as soon as possible.
Children and Adolescents
Norvir is not recommended for children under 2 years of age. For children aged 2 years and older, the dose will be determined by the doctor based on body weight and the specific protease inhibitor being boosted. Pediatric dosing should always follow current guidelines and the prescribing information for the co-administered protease inhibitor.
How Does Norvir Interact with Other Drugs?
Quick Answer: Norvir has one of the most extensive drug interaction profiles of any medication. As a potent CYP3A4 inhibitor, it can dramatically increase blood levels of many co-administered drugs, potentially causing serious or life-threatening toxicity. Always inform your doctor and pharmacist of all medications you take.
Ritonavir is one of the most potent inhibitors of the hepatic enzyme cytochrome P450 3A4 (CYP3A4) known in clinical medicine. Because CYP3A4 is involved in the metabolism of approximately 50% of all drugs on the market, ritonavir has an extraordinarily large number of clinically significant drug interactions. This property is both what makes it therapeutically valuable as a booster and what makes it potentially dangerous when combined with certain medications.
The contraindicated medications listed in the previous section must never be taken with Norvir. In addition to those absolute contraindications, the following drugs require special caution, dose adjustments, or enhanced monitoring when used alongside ritonavir:
Medications Requiring Special Caution
| Medication | Category | Clinical Concern |
|---|---|---|
| Sildenafil / Tadalafil (for erectile dysfunction) | PDE5 Inhibitor | Dose reduction required; risk of hypotension and priapism |
| Colchicine | Gout Treatment | Contraindicated with renal/hepatic impairment; dose reduction in others |
| Digoxin | Cardiac Glycoside | Increased digoxin levels; monitoring and dose adjustment required |
| Ethinylestradiol (hormonal contraceptives) | Hormonal Contraceptive | Reduced contraceptive efficacy; use barrier methods |
| Atorvastatin / Rosuvastatin | Statin | Increased statin levels; use lowest possible dose with monitoring |
| Fluticasone / Dexamethasone | Corticosteroid | Risk of Cushing’s syndrome and adrenal suppression |
| Trazodone | Antidepressant | Risk of nausea, dizziness, hypotension, and syncope |
| Rifampicin | Anti-tubercular | Risk of severe hepatotoxicity; avoid combination |
| Bosentan / Riociguat | PAH Treatment | Increased blood levels; dose adjustment required |
Other Medications to Report to Your Doctor
The following drug classes may also interact with Norvir and require careful clinical assessment. Always tell your doctor if you are taking any of these:
- Amphetamines and amphetamine derivatives
- Antibiotics (e.g., erythromycin, clarithromycin, rifabutin)
- Cancer treatments (e.g., abemaciclib, ibrutinib, venetoclax, vincristine)
- Anticoagulants (e.g., dabigatran, rivaroxaban, warfarin, edoxaban)
- Antidepressants (e.g., fluoxetine, sertraline, paroxetine, amitriptyline)
- Antifungals (e.g., ketoconazole, itraconazole, voriconazole)
- Other antiretrovirals including protease inhibitors (atazanavir, darunavir), NNRTIs, and other classes (maraviroc, raltegravir)
- Anti-tuberculosis drugs (bedaquiline, delamanid)
- Hepatitis C antivirals (e.g., glecaprevir/pibrentasvir, simeprevir)
- Anticonvulsants (e.g., carbamazepine, phenytoin, lamotrigine, valproate)
- Cardiac medications (e.g., calcium channel blockers such as amlodipine, diltiazem, nifedipine)
- Immunosuppressants (e.g., cyclosporine, tacrolimus, everolimus)
- Levothyroxine (thyroid medication)
- Opioid analgesics (e.g., methadone, fentanyl, buprenorphine)
- Sedatives (e.g., alprazolam, zolpidem, injectable midazolam, haloperidol, risperidone)
Due to the complexity of ritonavir’s drug interactions, healthcare providers are strongly advised to consult a comprehensive drug interaction database before prescribing any new medication to a patient taking Norvir. Online interaction checkers maintained by organizations such as the University of Liverpool HIV Drug Interactions database provide regularly updated, evidence-based guidance.
What Is the Correct Dosage of Norvir?
Quick Answer: The typical adult booster dose of Norvir is 100 mg (1 tablet) once or twice daily, taken with food. Tablets must be swallowed whole. Your doctor will determine the exact dose based on which protease inhibitor is being boosted.
Always take Norvir exactly as your doctor or pharmacist has instructed. Do not change your dose or stop taking the medication without first consulting your healthcare provider. The dosing of ritonavir depends entirely on which other antiretroviral medications it is being used alongside.
Adults
Standard Booster Dose
100 mg (1 tablet) once or twice daily, taken with food. The exact dosing frequency depends on the co-administered protease inhibitor. For example:
- With atazanavir: ritonavir 100 mg once daily
- With darunavir: ritonavir 100 mg once daily (treatment-experienced patients may require 100 mg twice daily)
- With lopinavir (co-formulated as Kaletra): ritonavir 100 mg twice daily
Refer to the prescribing information for the specific protease inhibitor for detailed dosage recommendations.
Children (2 Years and Older)
Pediatric Booster Dose
The dose for children is determined by body weight and the specific protease inhibitor being boosted. Your child’s doctor will calculate the appropriate dose. Ritonavir oral powder (100 mg sachets) may be used for children who cannot swallow tablets. Norvir is not recommended for children under 2 years of age.
Elderly Patients
Elderly Dosing
There is limited clinical data on the use of ritonavir in patients over 65 years of age. No specific dose adjustment recommendations are available, but elderly patients should be monitored more closely due to the greater frequency of decreased hepatic, renal, and cardiac function, as well as concomitant disease and other drug therapy.
Important Dosing Instructions
- Norvir tablets must be swallowed whole — do not chew, crush, or break them.
- Always take Norvir with food to improve absorption and reduce gastrointestinal side effects.
- Take Norvir at the same time each day to maintain consistent drug levels in your blood.
- Always keep an adequate supply of Norvir so that you do not run out, especially when traveling or if you need to be hospitalized.
- If a side effect prevents you from taking Norvir as prescribed, contact your doctor immediately — do not simply stop taking the medication.
Missed Dose
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one. Consistent adherence is critical to prevent the development of drug resistance.
Overdose
If you take more Norvir than prescribed, you may experience symptoms such as numbness, tingling, or a “pins and needles” sensation. If you suspect an overdose, contact your doctor immediately or go to the nearest emergency department. There is no specific antidote for ritonavir overdose; treatment is supportive.
Even if you feel better, do not stop taking Norvir without first talking to your doctor. Stopping antiretroviral therapy can allow the virus to replicate more rapidly and may lead to the development of drug-resistant HIV, which would make future treatment more difficult.
What Are the Side Effects of Norvir?
Quick Answer: Common side effects of Norvir include nausea, diarrhea, vomiting, abdominal pain, headache, dizziness, and tingling in the extremities. Because Norvir is always used with other antiretroviral drugs, the overall side effect profile also depends on the companion medications.
Like all medicines, Norvir can cause side effects, although not everybody gets them. Since Norvir is used in combination with other antiretroviral medications, the side effects you may experience are influenced by your entire drug regimen. It is therefore important to also read the patient information leaflets for your other medications.
During HIV treatment, weight gain and increased levels of lipids (fats) and glucose (sugar) in the blood may occur. This is partly related to improved health and lifestyle changes, but in the case of blood lipids, there may also be a direct association with the HIV medications themselves. Your doctor will perform regular tests to monitor these metabolic changes.
Very Common
May affect more than 1 in 10 people
- Upper or lower abdominal pain
- Vomiting
- Diarrhea (may be severe)
- Nausea
- Flushing, feeling of warmth
- Headache
- Dizziness
- Sore throat
- Cough
- Stomach or digestive discomfort
- Tingling or numbness in hands, feet, or around the mouth
- Weakness or tiredness
- Bad taste in the mouth
- Nerve damage causing weakness or pain
- Itching
- Rash
- Joint and back pain
Common
May affect up to 1 in 10 people
- Allergic reactions including skin rash (may be red, raised, or itchy), severe swelling of skin and tissues
- Difficulty sleeping (insomnia)
- Anxiety
- Increased cholesterol levels
- Increased triglyceride levels
- Gout
- Gastrointestinal bleeding
- Liver inflammation (hepatitis) and yellowing of skin/eyes (jaundice)
- Increased urination
- Decreased kidney function
- Seizures
- Decreased platelet count
- Thirst (dehydration)
- Abnormally heavy menstrual periods
- Bloating
- Loss of appetite
- Mouth ulcers
- Muscle pain, soreness, or weakness
- Fever
- Weight loss
- Confusion, difficulty concentrating
- Fainting, blurred vision
- Swelling in hands and feet
- High or low blood pressure
- Cold hands and feet
- Acne
Uncommon
May affect up to 1 in 100 people
- Heart attack (myocardial infarction)
- Diabetes mellitus
- Kidney failure
Rare
May affect up to 1 in 1,000 people
- Severe or life-threatening skin reactions including blisters (Stevens-Johnson syndrome, toxic epidermal necrolysis)
- Severe allergic reactions (anaphylaxis)
- Elevated blood sugar levels (hyperglycemia)
Frequency not known (cannot be estimated from available data): kidney stones.
Important Side Effect Warnings
Tell your doctor if you experience any of the following, as they may indicate a serious medical condition:
- Nausea, vomiting, or stomach pain — these may be signs of pancreatitis. Seek medical attention promptly.
- Joint stiffness, pain, and difficulty moving (especially in the hips, knees, and shoulders) — these may be signs of osteonecrosis.
- Unexplained or persistent muscle pain, tenderness, weakness, or cramps — stop the medication and contact your doctor immediately, as these may indicate rhabdomyolysis, a serious condition involving muscle breakdown.
- Abnormal liver test results, hepatitis, or jaundice — patients with pre-existing liver disease or hepatitis are at increased risk.
- Increased bleeding in patients with hemophilia type A or B.
- Signs of allergic reaction such as skin rash, itching, hives, or difficulty breathing — seek immediate medical attention.
How Should You Store Norvir?
Quick Answer: Store Norvir tablets in the original container at room temperature, protected from moisture. Keep out of sight and reach of children. Do not use after the expiry date.
Proper storage of Norvir is important to ensure the medication remains effective throughout its shelf life. Follow these guidelines:
- Keep this medicine out of the sight and reach of children.
- Do not use after the expiry date printed on the packaging. The expiry date refers to the last day of the stated month.
- No special temperature storage requirements — store at room temperature.
- Keep the tablets in the original container to protect from moisture.
- Do not use the medicine if you notice any discoloration of the tablets.
- Do not dispose of medicines via wastewater or household waste. Ask your pharmacist for proper disposal methods to help protect the environment.
What Does Norvir Contain?
Quick Answer: Each Norvir film-coated tablet contains 100 mg of ritonavir as the active ingredient, along with inactive ingredients used for tablet formulation and coating.
Active Ingredient
Each film-coated tablet contains 100 mg of ritonavir.
Inactive Ingredients (Excipients)
The tablet core contains: copovidone, sorbitan laurate, anhydrous calcium hydrogen phosphate, anhydrous colloidal silicon dioxide, and sodium stearyl fumarate.
The film coating consists of: hypromellose, titanium dioxide, macrogol, hydroxypropylcellulose, talc, colloidal anhydrous silicon dioxide, and polysorbate 80.
Appearance and Pack Sizes
Norvir film-coated tablets are white and embossed with the code “NK” on one side. They are available in the following pack sizes:
- 1 bottle of 30 tablets
- 1 bottle of 60 tablets
- Multipack containing 3 bottles of 30 tablets each (90 tablets total)
Not all pack sizes may be marketed in your country.
This medicine contains less than 1 mmol (23 mg) sodium per tablet, meaning it is essentially sodium-free. This is relevant for patients on sodium-restricted diets.
Driving and Operating Machinery
Norvir may cause dizziness. If you are affected, do not drive or operate machinery until you know how the medication affects you.
Frequently Asked Questions About Norvir
Norvir (ritonavir) is primarily used as a pharmacokinetic booster in combination with other HIV protease inhibitors. At low doses (100–200 mg), ritonavir inhibits CYP3A4 enzymes in the liver, which slows the breakdown of other protease inhibitors and increases their blood levels. This allows the co-administered protease inhibitor to work more effectively against HIV. Norvir is not used as a standalone HIV treatment at booster doses.
The most common side effects (affecting more than 1 in 10 people) include nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, tingling or numbness in hands and feet, skin rash, itching, fatigue, and altered taste. Since Norvir is always used with other antiretroviral drugs, the side effect profile also depends on the co-administered medications.
Norvir can be used during pregnancy under medical supervision. Extensive data from pregnant women (mostly after the first trimester) show that ritonavir used as a booster with other protease inhibitors does not appear to increase the risk of birth defects compared to the general population. However, breastfeeding is not recommended for women living with HIV, as the virus can be transmitted to the infant through breast milk. Always consult your healthcare provider.
Norvir (ritonavir) is one of the most potent inhibitors of the liver enzyme CYP3A4, which is responsible for metabolizing approximately 50% of all medications. By blocking this enzyme, ritonavir dramatically increases blood levels of many other drugs, potentially to dangerous concentrations. This is both its therapeutic benefit (boosting other protease inhibitors) and its greatest risk (causing toxic levels of contraindicated medications). Always inform your doctor of all medications you are taking.
Norvir tablets should be taken with food, either once or twice daily as prescribed by your doctor. The tablets must be swallowed whole — do not chew, break, or crush them. The most common booster dose for adults is 100 mg (1 tablet) once or twice daily. Always take Norvir at the same time each day and never stop taking it without consulting your doctor, as this could lead to drug resistance.
Several medications are absolutely contraindicated with Norvir due to the risk of life-threatening interactions. These include: simvastatin and lovastatin (cholesterol drugs), ergot derivatives (for migraines), oral midazolam and triazolam (sedatives), amiodarone and several other antiarrhythmics, pimozide and clozapine (antipsychotics), sildenafil for pulmonary arterial hypertension (but not for erectile dysfunction at reduced doses), and St. John’s Wort. Your doctor must review all your medications before starting Norvir.
References
This article is based on evidence from the following peer-reviewed sources and international guidelines:
- European Medicines Agency (EMA). Norvir – Summary of Product Characteristics (SmPC). Last updated 2025. Available at: ema.europa.eu
- U.S. Food and Drug Administration (FDA). Norvir (ritonavir) – Prescribing Information. AbbVie Inc. Available at: accessdata.fda.gov
- World Health Organization (WHO). Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring. Geneva: WHO; 2024.
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services (DHHS). Updated 2025.
- British HIV Association (BHIVA). BHIVA Guidelines for the Treatment of HIV-1-positive Adults with Antiretroviral Therapy. 2024.
- Liverpool HIV Drug Interactions. Interaction checker for ritonavir. University of Liverpool. Available at: hiv-druginteractions.org
- Flexner C. HIV-Protease Inhibitors. New England Journal of Medicine. 1998;338(18):1281-1292. doi:10.1056/NEJM199804303381808
- Zeldin RK, Petruschke RA. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. Journal of Antimicrobial Chemotherapy. 2004;53(1):4-9.
About Our Medical Editorial Team
This article has been written and reviewed by our medical editorial team, which includes specialists in infectious disease, clinical pharmacology, and internal medicine. All content follows the GRADE evidence framework and adheres to international guidelines from the WHO, EMA, and FDA.
All medical claims are supported by peer-reviewed research, systematic reviews, and international clinical guidelines. We use evidence level 1A as our standard — the highest quality of evidence.
iMedic receives no commercial funding from pharmaceutical companies. Our content is completely independent and free from industry influence, ensuring unbiased medical information.